Mgfamiliar

Levin EG et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med 2021 Oct 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2114583) Chemaitelly H et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 2021 Oct 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2114114) Tartof SY et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 2021 Oct 4; [e-pub]. (https://doi.org/10.1016/S0140-6736(21)02183-8)